A Phase I study of patients with advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer
Phase 1
Completed
- Conditions
- Patients with epithelial ovarian, primary peritoneal, or fallopian tube cancer
- Registration Number
- JPRN-jRCT2080223109
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Patients who provided written informed consent to participate as subjects of this study
- Patients who have histologically or cytologically proven epithelial ovarian, primary peritoneal, or fallopian tube cancer
- Other
Exclusion Criteria
- Patients with severe diseases or medical conditions
- Other
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method